James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Twitter Inc: Longer Tweets Are a Glimmer of Hope (TWTR)

It's premature to bet the farm on Twitter stock just yet, but if Jack Dorsey can figure out WHY longer tweets are a good thing, the microblogging platform may yet survive.

Why Pandora Media Inc. (P), General Motors Company (GM) and Fitbit Inc. (FIT) Are 3 of Today’s Worst Stocks

Pandora Media (P), General Motors (GM) and Fitbit (FIT) were battered and bruised on Tuesday, though for understandable reasons.

Yahoo Screen’s Demise Follows Familiar Pattern for YHOO Stock Owners

YHOO stock was a miserable performer in 2015, but the reason for the company's floundering becomes clearer in the shadow of this week's news regarding Yahoo! Screen.

Buy Time Warner, Netflix Isn’t Slaughtering Cable TV (TWC, NFLX)

Time Warner Cable has been struggling to fend off Netflix (and other alternatives) for years, but a winning formula has finally been found.

Buy Gilead (GILD) for Deep-Rooted Growth in 2016

Gilead Sciences (GILD) was lackluster in 2015 on concerns Sovaldi and Harvoni were priced unsustainably, but the dust is settling, and both drugs are still standing.